- Is REGROW Act anti-embryo research? Pluripotent stem cells excluded
- REGROW Act 2.0 still no-go with big risks to patients & field
- REGROW Act to do reappearing act?
- Pay clinical trials? 70% negative polling
- Blogging today’s FDA stem cell meeting: Part 1
- Stem cell headlines: half a genome, Australian snake oil, CRISPR patent battle